Innovation
Spotlight on OHE: Assessing Value and Balancing Needs in Health Care
15 December 2011
During the last quarter of 2011, OHE team members were involved in discussions and presentations in a range of forums, covering each of OHE’s three areas…
Research Funding and Economic Growth
9 December 2011
Increasingly, governments in the UK and throughout Europe see R&D driven growth as the best way out of the financial crisis. The Government identifies the ‘UK’s…
Upcoming OHE Seminars: MCDA and R&D Productivity
16 November 2011
Join OHE for two exciting seminars, one on MCDA and the other on shifts in investment in R&D.
Antibacterials: Roundtable Addresses the Critical Issues
10 November 2011
Antibacterial drug resistance is a serious and growing worldwide problem that threatens our ability to cure traditionally treatable diseases and to successfully perform numerous surgical procedures…
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
This post reviews OHE’s activities in September 2011 that contributed to advancing thought and stimulating innovative ideas in its three key research areas: financing and delivery…
OHE in the Spotlight: Summer 2011
22 September 2011
This is the first in a series of posts that will review OHE’s contributions to advancing thought and stimulating innovative ideas in its three key research…
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
Just published by OHE researchers is a comprehensive analysis of what policy measures are needed to counter the growing global problem of antimicrobial resistance. Their key…
Recent Statistics on Orphan Approvals in Scotland and England
23 August 2011
In October 2009, the OHE published research that compared access to orphan medicinal products (OMPs) in selected European countries. At the request of the UK Orphan…
Pricing in Emerging Markets: Income, Competition and Procurement
16 August 2011
Most patients in middle and low income countries (MLICs) lack insurance coverage and so pay out of pocket for prescription medicines; pricing commensurate with income thus…